News

Due to a recent case anti-ageing drugs and injections are under radar There are a lot of risks involved with these including ...
Across the world, millions struggle with memory lapses, brain fog, and reduced concentration due to age, stress, digital ...
We rounded up the best dermatologist-approved treatments for getting rid of under-eye bags and puffy skin, from surgery and ...
In Study 2 of the pivotal Phase 3 UP-AA clinical program, upadacitinib (RINVOQ®) achieved the primary endpoint, demonstrating that 44.6% and 54.3% of ...
With integrated clinical, lab, and research teams onsite, BostonSight expands its capacity to support trials advancing the ...
GLP-1 receptor agonists are an important drug class and have become widely popular due to their effectiveness in weight ...
Tixel i, an FDA-cleared treatment, utilizes gentle Thermo-Mechanical Action® to apply heat and pressure directly to the meibomian glands, enhancing oil secretion and targeting the root cause of dry ...
Antibody-drug conjugates are a growing class of biopharmaceuticals that combine the precision of monoclonal antibodies with ...
With inflammation being the cause of dry eye in many cases, future treatment will likely target this aspect of dry eye.
Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.
Exonate Ltd., a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases, today announced plans to initiate a Phase IIb clinical ...